The US Under Secretary of State Victoria Nuland confirmed that “Ukraine has biological research facilities” run by the US at the congressional hearing last week.
According to documents published on
Reddit, Pentagon contractors were given full unrestricted access by the Ukrainian minister of health Ulyana Suprun in July 2019 to operate in all biolabs in Ukraine funded by the Defense Threat Reduction agency (DTRA) allocated $80 million for biological research in Ukraine as of 30 July 2020, according to the US Federal contracts registry. The US company Black & Veatch Special Projects Corp. was tasked with the program and was given full access and engaged in biological research activities under the DTRA program, according to a letter dated 2 July 2019 from the Ukrainian minister of health Ulyana Suprun to DTRA.
Germany had conducted its work with biological agents in Ukraine as well.
No public review of any work in bio labs was allowed.
“The Ministry of Health of Ukraine considers it inappropriate to create a working group for public control and it is not possible to allow members of the group to enter the premises of laboratories of especially dangerous infections of the Ministry of Health of Ukraine”, according to a letter dated 21 October 2016 from the Ukrainian Deputy Minister for European Integration Oksana Sivak to the scientific journal “Problems of innovation and investment development”.
Another DTRA contractor that operated in Ukraine was CH2M Hill was tasked with an $11.6 million program “Countering Especially Dangerous Pathogen Threats in Ukraine” and awarded contracts for reconstruction of two bio labs: the State Scientific Research Institute of Laboratory Diagnostics and Veterinary-Sanitary Expertise (Kyiv ILD) and the State Service of Ukraine for Food Safety and Consumer Protection Regional Diagnostic Laboratory (Odesa RDL)
According to the project’s description, the main goal of these projects was to carry out sequencing and study including molecular genetic changes of orthomyxoviruses H5-7-9 (causing bird/avian flu) genomes that have 50% fatality rate , biological agents with pathogenicity group 2-4, as well to discover new viruses in birds.